Medios AG (0QB4.L)
0QB4.L Stock Price Chart
Explore Medios AG interactive price chart. Choose custom timeframes to analyze 0QB4.L price movements and trends.
0QB4.L Company Profile
Discover essential business fundamentals and corporate details for Medios AG (0QB4.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
7 Nov 2017
Employees
472.00
Website
https://www.medios.agCEO
Matthias Gaertner
Description
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
0QB4.L Financial Timeline
Browse a chronological timeline of Medios AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
Upcoming earnings on 13 Aug 2025
Earnings released on 13 May 2025
Revenue for the quarter reached €484.70M.
Earnings released on 4 Mar 2025
EPS came in at €0.08 falling short of the estimated €0.25 by -66.85%, while revenue for the quarter reached €482.53M, beating expectations by +6.00%.
Earnings released on 12 Nov 2024
EPS came in at €0.16, while revenue for the quarter reached €493.24M, missing expectations by -9.06%.
Earnings released on 13 Aug 2024
EPS came in at €0.10 falling short of the estimated €0.18 by -45.44%, while revenue for the quarter reached €451.04M, missing expectations by -1.95%.
Earnings released on 7 May 2024
EPS came in at €0.17, while revenue for the quarter reached €456.22M.
Earnings released on 27 Mar 2024
EPS came in at €0.10, while revenue for the quarter reached €441.25M.
Earnings released on 30 Sept 2023
EPS came in at €0.30 surpassing the estimated €0.28 by +6.57%, while revenue for the quarter reached €489.94M, beating expectations by +5.93%.
Earnings released on 30 Jun 2023
EPS came in at €0.19 falling short of the estimated €0.23 by -18.96%, while revenue for the quarter reached €422.28M, missing expectations by -2.84%.
Earnings released on 31 Mar 2023
EPS came in at €0.20, while revenue for the quarter reached €431.24M.
Earnings released on 31 Dec 2022
EPS came in at €0.10 falling short of the estimated €0.27 by -61.44%, while revenue for the quarter reached €399.38M, beating expectations by +0.02%.
Earnings released on 30 Sept 2022
EPS came in at €0.25, while revenue for the quarter reached €419.22M, missing expectations by -0.42%.
Earnings released on 30 Jun 2022
EPS came in at €0.21, while revenue for the quarter reached €399.22M, beating expectations by +0.92%.
Earnings released on 31 Mar 2022
EPS came in at €0.21 falling short of the estimated €0.22 by -3.82%, while revenue for the quarter reached €392.96M, missing expectations by -1.22%.
Dividend declared on 15 Mar 2022
A dividend of €0.29 per share was announced, adjusted to €0.29.
Earnings released on 31 Dec 2021
EPS came in at -€0.11, while revenue for the quarter reached €368.64M.
Earnings released on 30 Sept 2021
EPS came in at €0.17, while revenue for the quarter reached €353.84M, missing expectations by -0.89%.
Earnings released on 30 Jun 2021
EPS came in at €0.17, while revenue for the quarter reached €319.02M.
Earnings released on 31 Mar 2021
EPS came in at €0.14, while revenue for the quarter reached €315.91M.
Earnings released on 31 Dec 2020
EPS came in at €0.08, while revenue for the quarter reached €173.98M.
Earnings released on 30 Sept 2020
EPS came in at €0.07, while revenue for the quarter reached €160.02M.
0QB4.L Stock Performance
Access detailed 0QB4.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.